bookmark

Promising Results Reported in First U.S. Clinical Trial Investigating the Use of Adult Stem Cells for Severe Coronary Artery Disease


Description

Results from the first U.S. clinical trial investigating the benefit of using a patient's own (autologous) selected adult stem cells, called CD34+ cells, to treat coronary artery disease are promising.

Preview

Tags

Users

  • @avivagabriel

Comments and Reviews